StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) PT Raised to $95 at Morgan Stanley
May 2, 2024 4:14 PM
Morgan Stanley analyst Matthew Harrison raised the price target on Moderna (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Moderna (MRNA) PT Raised to $135 at RBC Capital
May 3, 2024 6:45 AM
Form 10-Q Moderna, Inc. For: Mar 31
May 2, 2024 4:04 PM
Midday movers: Carvana and Qualcomm rise; DoorDash, Fastly, Zillow fall
May 2, 2024 7:53 AM
Moderna (MRNA) beats estimates in Q1 2024, targets RSV vaccine launch in fall
May 2, 2024 6:44 AM
Moderna (MRNA) Tops Q1 EPS by 48c
May 2, 2024 6:35 AM
Moderna quarterly sales beat expectations but plummet from previous year
May 2, 2024 6:33 AM
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
May 2, 2024 6:34 AM
Form 8-K Moderna, Inc. For: May 02
May 2, 2024 6:31 AM
Powell speech, Apple results, OECD growth - what's moving markets
May 2, 2024 4:40 AM
Moderna (MRNA) May weekly 111 straddle into quarter results before the bell on May 2.
May 2, 2024 2:55 AM
Form 144 Moderna, Inc. Filed by: AFEYAN NOUBAR
May 1, 2024 4:30 PM
Moderna (MRNA) May weekly option implied volatility into quarter results
May 1, 2024 10:41 AM
